Related Experiment Video
Updated: Sep 11, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
CONNECT Platform to Increase Diverse Engagement and Enrollment in Cardiovascular Clinical Research: Rationale,
Hailey N Miller1,2, Erin Wong1, Samuel Byiringiro1
1School of Nursing Johns Hopkins University Baltimore MD USA.
The CONNECT platform aims to increase cardiovascular disease (CVD) research participation among women and Black and Latino adults through community engagement and tailored education. Early results show promise in addressing participation barriers and improving diverse enrollment in clinical trials.
Area of Science:
- Cardiovascular Disease Research
- Clinical Trial Recruitment
- Health Equity
Background:
- Women and Black and Latino adults experience a high burden of cardiovascular disease (CVD) but are underrepresented in research.
- The CONNECT platform was developed to address these disparities in clinical trial participation.
- A key focus is on improving trust and awareness of CVD research within these priority populations.
Purpose of the Study:
- To evaluate electronic health record-informed and community-engaged recruitment strategies.
- To increase enrollment of women and Black and Latino adults in cardiovascular disease research.
- To enhance trust in and awareness of CVD research among priority populations.
Main Methods:
- Utilized community-engaged and digital approaches to recruit and engage 1000 participants.
- Provided 12 months of tailored heart health and research-related text messages.
- Connected participants to CVD research aligned with their interests, with outcomes measured by enrollment proportion and changes in awareness/trust.
Main Results:
- Identified strategies for successful community partnerships and cross-institutional collaboration.
- Developed efficient technology infrastructures and tailored educational materials.
- Facilitated researcher engagement and effective implementation of the CONNECT platform.
Conclusions:
- The CONNECT platform demonstrates potential to overcome barriers to research participation.
- It offers a model for strengthening engagement and recruitment science in clinical trials.
- Findings will inform best practices for engaging diverse populations in cardiovascular disease research.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures

